Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Depreciation & Amortization (CF): 2024-2025

Historic Depreciation & Amortization (CF) for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $164,000.

  • Kura Oncology's Depreciation & Amortization (CF) fell 21.15% to $164,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $833,000, marking a year-over-year change of. This contributed to the annual value of $848,000 for FY2024, which is 0.12% down from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's Depreciation & Amortization (CF) is $164,000, which was down 26.79% from $224,000 recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Depreciation & Amortization (CF) ranged from a high of $241,000 in Q1 2025 and a low of $164,000 during Q3 2025.